Risk Factor of Morbidity and Mortality of Surgical Resection after Induction Therapy in Patients with Stage IIIA-N2 Lung Cancer

被引:0
|
作者
Cho, Jong Ho [1 ]
Kim, Jhingook [1 ]
Kim, Hong Kwan [1 ]
Choi, Yong Soo [1 ]
Zo, Jae Ill [1 ]
Shim, Young Mog [1 ]
Kim, Kwhanmien [2 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, Seoul, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Bundang Hosp, Seoul, South Korea
关键词
non-small cell lung cancer; Surgery;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MINI07.07
引用
收藏
页码:S287 / S288
页数:2
相关论文
共 50 条
  • [1] Resection of Persistent Stage IIIA-N2 Non-small Cell Lung Cancer After Induction Therapy
    Andrews, Weston G.
    Louie, Brian E.
    Bograd, Adam J.
    [J]. ANNALS OF THORACIC SURGERY, 2022, 114 (06): : 2392 - 2393
  • [2] The Importance of Sleeve Lobectomy after Induction Therapy for Patients with Stage IIIA-N2 Lung Cancer: The Avoidance of Pneumonectomy
    Cho, Jong Ho
    Choi, Yong Soo
    Kim, Jhingook
    Kim, Hong Kwan
    Zo, Jae Ill
    Shim, Young Mog
    Kim, Kwhanmien
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S336 - S336
  • [3] Morbidity and Mortality after Induction Chemotherapy Followed by Surgery in IIIa-N2 non Small Cell Lung Cancer
    Borreman, Ph.
    De Leyn, P.
    Decaluwe, H.
    Moons, J.
    Van Raemdonck, D.
    Nafteux, Ph.
    Coosemans, W.
    Lerut, T.
    [J]. ACTA CHIRURGICA BELGICA, 2009, 109 (03) : 333 - 339
  • [4] Induction erlotinib therapy in stage IIIA-N2 non-small cell lung cancer
    Zhong Wen-Zhao
    Yang Xue-Ning
    Guo Ai-Lin
    Chen Hua-Jun
    Su Jian
    Liao Ri-Qiang
    Zhou Qing
    Nie Qiang
    Xu Chong-Rui
    Yang Jin-Ji
    Wu Yi-Long
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S590 - S591
  • [5] Induction eriotinib therapy in stage IIIA-N2 non-small cell lung cancer
    Zhong, W.
    Yang, X.
    Liao, R.
    Nie, Q.
    Zhang, X.
    Su, J.
    Zhou, Q.
    Xu, C.
    Yang, J.
    Wu, Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Induction chemotherapy and surgical treatment in stage IIIA-N2 INSCLC
    Athanassiadis, G.
    Pavlidu, Ch
    Andronadi, V
    Zogana, S.
    Zoganas, L.
    [J]. LUNG CANCER, 2007, 55 : S4 - S5
  • [7] Hyperfractionated Irradiation with 3 Cycles of Induction Chemotherapy in Stage IIIA-N2 Lung Cancer
    Fengshi Chen
    Kenichi Okubo
    Makoto Sonobe
    Keiko Shibuya
    Yukinori Matsuo
    Young Hak Kim
    Kazuhiro Yanagihara
    Toru Bando
    Hiroshi Date
    [J]. World Journal of Surgery, 2012, 36 : 2858 - 2864
  • [8] Hyperfractionated Irradiation with 3 Cycles of Induction Chemotherapy in Stage IIIA-N2 Lung Cancer
    Chen, Fengshi
    Okubo, Kenichi
    Sonobe, Makoto
    Shibuya, Keiko
    Matsuo, Yukinori
    Kim, Young Hak
    Yanagihara, Kazuhiro
    Bando, Toru
    Date, Hiroshi
    [J]. WORLD JOURNAL OF SURGERY, 2012, 36 (12) : 2858 - 2864
  • [9] Induction Chemoradiotherapy (50 Gy), Followed by Resection, for Stage IIIA-N2 Non-Small Cell Lung Cancer
    Tanaka, Fumihiro
    Yokomise, Hiroyasu
    Soejima, Toshinori
    Uramoto, Hidetaka
    Yamanaka, Takeharu
    Nakagawa, Kazuhiko
    Yamamoto, Nobuyuki
    Nishimura, Yasumasa
    Niwa, Hiroshi
    Okada, Morihito
    Nakagawa, Tatsuo
    Yamashita, Motohiro
    [J]. ANNALS OF THORACIC SURGERY, 2018, 106 (04): : 1018 - 1024
  • [10] Survival of Patients with Persistent N1 or N2 Disease After Induction Therapy for Stage IIIA-N2 Non-Small-Cell Lung Cancer
    Beqari, J.
    Potter, A.
    Pan, M.
    Copeland, J.
    Lanuti, M.
    Yang, C.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S884 - S884